Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00430586 | Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines | ||
| NCT00827008 | Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus | ||
| NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | ||
| NCT03650387 | Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face | ||
| NCT00983099 | Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects | ||
| NCT06091020 | A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury | ||
| NCT00624026 | Memantine - Communication Study | ||
| NCT07018700 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine | ||
| NCT01565395 | Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT00432666 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb | ||
| NCT02462317 | Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment | ||
| NCT04792398 | Bruxism Xeomin® Intervention Trial | ||
| NCT03992404 | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury | ||
| NCT01714960 | Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients | ||
| NCT03256942 | Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation | ||
| NCT01464307 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke | ||
| NCT02212119 | Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness | ||
| NCT01900041 | A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss | ||
| NCT00777803 | NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines | ||
| NCT03986424 | Local Study of Akatinol Memantine in VaD in Russia | ||
| NCT00507637 | Blepharospasm Short Interval | ||
| NCT02091739 | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions | ||
| NCT00712283 | Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers | ||
| NCT01305187 | Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 | ||
| NCT05327972 | DEgenerative ROtator Cuff Disease and Botulinum TOXin | ||
| NCT02270736 | Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability | ||
| NCT04075981 | Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) | ||
| NCT04177212 | Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles | ||
| NCT00694148 | Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines | ||
| NCT01109680 | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | ||
| NCT04908423 | Xeomin® and Gait Related Mobility After Stroke | ||
| NCT00955799 | Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus | ||
| NCT01910896 | Effectiveness and Safety Study of Overnight Intensive Patch in Scars | ||
| NCT00429520 | Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds | ||
| NCT04594213 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT01686061 | Blepharospasm Patient Survey for Patients With Blepharospasm | ||
| NCT06995287 | Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea | ||
| NCT07486830 | IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction | ||
| NCT00430963 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines | ||
| NCT07473635 | Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study | ||
| NCT00512135 | Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines | ||
| NCT01896895 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid | ||
| NCT00872898 | Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism | ||
| NCT02002884 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy | ||
| NCT03119948 | Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis | ||
| NCT01893411 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy | ||
| NCT00661440 | Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT00955760 | Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate | ||
| NCT00936026 | Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane | ||
| NCT03806933 | Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines |
